Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by severe microcephaly, agyria, agenesis of the corpus callosum, cerebellar hypoplasia, facial dysmorphology and epiphyseal stippling of the metacarpal bones. It has been described in two brothers. The syndrome is transmitted as an autosomal recessive trait and may be an allelic variant of Neu-Laxova syndrome and Lissencephaly type III with cystic dilations of the cerebellum and fetal akinesia sequence.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for lissencephaly type 3-metacarpal bone dysplasia syndrome.
4 publications have been identified in PubMed for lissencephaly type 3-metacarpal bone dysplasia syndrome. Research spans Review / Meta-Analysis (50%), Other (25%), and Epidemiology / Natural History (25%).
Ünsal Y (2026). [PMID: 39975416](https://pubmed.ncbi.nlm.nih.gov/39975416/). *J Clin Res Pediatr Endocrinol*. [Review / Meta-Analysis]
Tolmacheva EN (2025). [PMID: 39985054](https://pubmed.ncbi.nlm.nih.gov/39985054/). *Mol Cytogenet*. [Epidemiology / Natural History]
Gogate N (2025). [PMID: 40666329](https://pubmed.ncbi.nlm.nih.gov/40666329/). *medRxiv*. [Other]
Bonati MT (2024). [PMID: 38927613](https://pubmed.ncbi.nlm.nih.gov/38927613/). *Genes (Basel)*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center